TM6SF2 and metabolic dysfunction-associated steatotic liver disease: Although accumulation of TGs is the major phenotype in E167K carriers or when TM6SF2 is knocked down, neutral lipids like TGs may not cause NAFLD-associated liver damage, but rather the accumulation of other more toxic lipids may determine severity and progression of NAFLD.